Financials

  • Market Capitalization 9.1 B
  • Employee 507
  • Founded 2013
  • CEO N/A
  • Website www.vaxcyte.com
  • Headquarter Delaware, United States
  • FIGI BBG009PHHPL8
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.2
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
925
KYMR
Kymera Therapeutics, Inc. - Common Stock
120.23 USD-4.24%-2.15%+14.50%+103.43%10.00 B USD
943
PTGX
Protagonist Therapeutics, Inc. - Common Stock
149.50 USD-1.32%-1.36%+9.20%+98.99%9.67 B USD
983
IMVT
Immunovant, Inc. - Common Stock
43.82 USD-0.16%-2.03%+12.42%+128.11%9.05 B USD
992
CRNX
Crinetics Pharmaceuticals, Inc. - Common Stock
84.85 USD+0.01%+0.18%+1.14%+106.45%9.00 B USD

Frequently asked questions about Vaxcyte, Inc. Common Stock

What is the Vaxcyte, Inc. Common Stock stock price today?

The current price of Vaxcyte, Inc. Common Stock (PCVX) is 61.16. Over the past 24 hours, the stock has changed by +0.11%. Follow the PCVX chart for real-time price dynamics.

What is the stock ticker of Vaxcyte, Inc. Common Stock?

Vaxcyte, Inc. Common Stock trades under the ticker PCVX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Vaxcyte, Inc. Common Stock stock going up?

PCVX has changed by -1.12% over the last week, +12.22% over the last month, and +44.59% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Vaxcyte, Inc. Common Stock?

Vaxcyte, Inc. Common Stock currently has a market capitalization of 9.1 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Vaxcyte, Inc. Common Stock earnings last quarter?

Last quarter, Vaxcyte, Inc. Common Stock reported earnings of -1.97 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Vaxcyte, Inc. Common Stock net income for the last quarter?

Vaxcyte, Inc. Common Stock reported net income of -284.3 M for the last quarter. The previous quarter showed -320.62 M, which means net income changed by +11.33%.

How many employees does Vaxcyte, Inc. Common Stock have?

As of the latest available data, Vaxcyte, Inc. Common Stock has 507 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Vaxcyte, Inc. Common Stock stock?

You can buy Vaxcyte, Inc. Common Stock (PCVX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Vaxcyte, Inc. Common Stock stock?

Investing in Vaxcyte, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PCVX chart and related analysis on metatrader.com as part of your research.

News